Exosome / stem-cell culture supernatant therapy
Photo: Norlanya · CC BY 2.0Overview
IV drips or skin injections of products derived from stem-cell culture fluid (culture supernatant) or extracellular vesicles such as exosomes, marketed by some clinics for anti-aging or skin. Scientific evidence of benefit is limited.
Time needed / downtime
Short session; bruising, pain or allergic reactions are possible.
Reference price
Price on request
Legal note
Not currently covered by the cell-based framework of the Act on the Safety of Regenerative Medicine (it is not a cell product). MHLW stated in July 2024 that no exosome/culture-supernatant medicine has been approved with proven efficacy and safety and that physicians bear responsibility for safety; products sold as 'reagents' are not approved drugs. As of 2026 an MHLW working group was discussing whether to bring these treatments under the Act.
Reference range from published sources. Actual cost is set by the facility's quote.
Facilities offering this (4)




Good to know
Medical Stay Visa: who qualifies
Japan's Visa for Medical Stay is for foreign nationals who come to receive medical services at a Japanese medical institution. It covers not only treatment but also full medical check-ups (Ningen Dock), examinations, dental care and recuperation such as hot-spring therapy (90 days or less). Applicants need a certificate from the receiving institution and a letter from a registered guarantor, and apply at a Japanese embassy or consulate. A multiple-entry visa can be issued when each stay is 90 days or less; stays over 90 days require hospitalization and a Certificate of Eligibility. Stay limits on MOFA's different language pages differ, so check the current page.
Source: mofa.go.jp ↗Medical Stay Visa: accompanying persons
Family members and, where needed, non-family members may accompany the patient and receive the same type of visa. Accompanying persons may not work or engage in paid activities in Japan, and submit a reduced set of documents (passport, application form, photo, the hospital certificate/guarantor letter and proof of identity).
Source: mofa.go.jp ↗Registered guarantors (身元保証機関) and how they are registered
A Medical Stay Visa application must go through a registered guarantor. Travel agencies registered under the Travel Agency Act are screened and registered by the Japan Tourism Agency and MOFA (List A); medical coordinators and other non-travel-agency companies are screened and registered by METI and MOFA (List B). Both lists are published on MOFA's website. The guarantor confirms the patient's plan with the hospital, coordinates medical-fee arrangements and helps ensure compliance with Japanese law during the stay.
Source: meti.go.jp ↗Number of registered guarantors
According to a Japan Economic Foundation report, as of September 2025 there were 217 registered guarantor companies for the Medical Stay Visa: 77 travel agencies and 140 non-travel-agency companies. Patients should check that any agent they use appears on MOFA's current lists.
Source: jef.or.jp ↗AMTAC: accredited medical travel assistance companies
Separately from visa guarantor registration, Medical Excellence JAPAN (MEJ) accredits medical travel support companies as AMTAC. A September 2025 report listed four fully accredited companies (including JTB) and two provisionally accredited ones, with travel-agency registration among the requirements. Arranging travel for patients generally requires compliance with the Travel Agency Act.
Source: travelvoice.jp ↗Medical advertising rules cover websites
Under Japan's Medical Care Act and MHLW's Medical Advertising Guidelines (latest revision dated 30 March 2026), content counts as an advertisement if it is intended to attract patients and identifies a specific provider. Clinic websites are covered. Third-party sites such as review portals are generally not treated as advertising unless a clinic pays for or otherwise arranges the listing – so paid listings, affiliate fees or referral commissions can bring an aggregator's pages under the rules.
Source: mhlw.go.jp ↗Articles

Injections in Japan: vaccines, IV drips and regenerative medicine
The 9-valent HPV vaccine, high-dose vitamin C drips, stem cells — all are 'injections', but their legal status in Japan is very different.
Updated 2026-11-20 · 5 sources · 2 min readFAQ
How long does Exosome / stem-cell culture supernatant therapy take?
Short session; bruising, pain or allergic reactions are possible.
Where can I get Exosome / stem-cell culture supernatant therapy in Japan?
Facilities accepting international patients include Tokyo Midtown Clinic / Medical Center, Tokyo Business Clinic (Yaesu North Exit), Bianca Clinic (Ginza / Omotesando), Iseikai International General Hospital.
Are there legal points to know about Exosome / stem-cell culture supernatant therapy?
Not currently covered by the cell-based framework of the Act on the Safety of Regenerative Medicine (it is not a cell product). MHLW stated in July 2024 that no exosome/culture-supernatant medicine has been approved with proven efficacy and safety and that physicians bear responsibility for safety; products sold as 'reagents' are not approved drugs. As of 2026 an MHLW working group was discussing whether to bring these treatments under the Act.


